Publication Cover
Journal of Dual Diagnosis
research and practice in substance abuse comorbidity
Volume 10, 2014 - Issue 2
538
Views
11
CrossRef citations to date
0
Altmetric
PSYCHOTHERAPY & PSYCHOSOCIAL ISSUES

Convergent Validity of the ASAM Criteria in Co-Occurring Disorders

, MD & , PhD

REFERENCES

  • American Psychiatric Association. (2000). Diagnostic and statistical manual of mental disorders (4th ed., text rev.). Washington, DC: Author. doi:10.1176/appi.books.9780890423349
  • Angarita, G.A., Reif, S., Pirard, S., Lee, S., Sharon, E., & Gastfriend, D.R. (2007). No-show for treatment in substance abuse patients with comorbid symptomatology: Validity results from a controlled trial of the ASAM patient placement criteria. Journal of Addiction Medicine, 1(2), 79–87. doi:10.1097/ADM.0b013e3180634c1d
  • Baker, S.L., & Gastfriend, D.R. (2003). Reliability of multidimensional substance abuse treatment matching: Implementing the ASAM patient placement criteria. Journal of Addictive Diseases, 22(Suppl. 1), 45–60.
  • Bakken, K., Landheim, A.S., & Vaglum, P. (2005). Substance-dependent patients with and without social anxiety disorder: Occurrence and clinical differences: A study of a consecutive sample of alcohol-dependent and poly-substance-dependent patients treated in two counties in Norway. Drug and Alcohol Dependence, 80(3), 321–328. doi:10.1016/j.drugalcdep.2005.04.011
  • Bakken, K., & Vaglum, P. (2007). Predictors of suicide attempters in substance-dependent patients: A six-year prospective follow-up. Clinical Practical Epidemiological Mental Health, 3, 20. doi:10.1186/1745-0179-3-20
  • Bartak A., Andrea H.Spreeuwenberg,, M. D., ZieglerU. M.,, Dekker J., RossumB. V.,, Hamers, E. F., Scholte, W.Aerts, J.,, Busschbach, J. J., Verheul, R., StijnenT., Emmelkamp, P. M., (2011). Effectiveness of outpatient, day hospital, and inpatient psychotherapeutic treatment for patients with cluster B personality disorders. Psychotherapy and Psychosomatics, 80, 28–38.
  • Brunette, M.F., Mueser, K.T., & Drake, R.E. (2004). A review of research on residential programs for people with severe mental illness and co-occurring substance use disorders. Drug and Alcohol Review, 23, 471–481. doi:10.1080/09595230412331324590
  • Center for Substance Abuse Treatment. (1995). The role and current status of patient placement criteria in the treatment of substance use disorders. Treatment Improvement Protocol (TIP) Series 13. Rockville, MD: Substance Abuse and Mental Health Services Administration.
  • Chen, S., Barnett, P.G., Sempel, J.M., & Timko, C. (2006). Outcomes and cost of matching the intensity of dual-diagnosis treatment to patients’ symptom severity. Journal of Substance Abuse Treatment, 31, 95–105. doi:10.1016/j.jsat.2006.03.015
  • Cohen, L.R., Greenfield, S.F., Gordon, S., Killeen, T., Jiang, H.P., Zhang, Y.L., & Hien, D. (2010). Survey of eating disorder symptoms among women in treatment for substance abuse. American Journal on Addictions, 19(3), 245–251.
  • Cole, M., & Sacks, T. (2008). When dual diagnosis means no diagnosis: Co-occurring mental illness and problematic drug use in clients of alcohol and drug services in eastern metropolitan Melbourne. Mental Health and Substance Use, 1(1), 33–43. doi:10.1080/17523280701747289
  • Darke, S., Ross, J., Lynskey, M., & Teesson, M. (2004). Attempted suicide among entrants to three treatment modalities for heroin dependence in the Australian Treatment Outcome Study (ATOS): Prevalence and risk factors. Drug and Alcohol Dependence, 73, 1–10. doi:10.1016/j.drugalcdep.2003.08.008
  • Dausey, D.J., & Desai, R.A. (2003). Psychiatric comorbidity and the prevalence of HIV infection in a sample of patients in treatment for substance abuse. The Journal of Nervous and Mental Disease, 191(1), 10–17. doi:10.1097/00005053-200301000-0000
  • Grant, B.F., Stinson, F.S., Dawson, D.A., Chou, S.P., Dufour, M.C., Compton, W., … Kaplan, K. (2004). Prevalence and co-occurrence of substance use disorders and independent mood and anxiety disorders: Results from the National Epidemiologic Survey on Alcohol and Related Conditions. Archives of General Psychiatry, 61(8), 807–816. doi:10.1001/archpsyc.61.8.807
  • Helseth, V.Samet,, S., Johnsen, J., Bramness, J., & Waal, H. (2013). Independent or substance-induced mental disorders? An investigation of comorbidity in an acute psychiatric unit. Journal of Dual Diagnosis, 9, 78–86. doi:10.1080/15504263.2012.749142
  • Hides, L., Dawe, S., Young, R., & Kavanagh, D. (2007). The reliability and validity of the Severity of Dependence Scale for detecting cannabis dependence in psychosis. Addiction, 102, 35–40. doi:10.1111/j.1360-0443.2006.01669.x
  • Hodgins, D.C., & El-Guebaly, N. (1992). More data on the Addiction Severity Index. Reliability and validity with the mentally ill substance abuser. The Journal of Nervous and Mental Disease, 180(3), 197–201.
  • Hoffmann, N., Halikas, J., Mee-Lee, D., & Weedman, R. (1991). American Society of Addiction Medicine-patient placement criteria for the treatment of psychoactive substance use disorders. Washington, DC: American Society of Addiction Medicine, Inc.
  • Kashner, T.M., Rader, L.E., Rodell, D.E., Beck, C.M., Rodell, L.R., & Muller, K. (1991). Family characteristics, substance abuse, and hospitalization patterns of patients with schizophrenia. Hospital and Community Psychiatry, 42, 195–197.
  • Kavanagh, D.J., Waghorn, G., Jenner, L., Chant, D.C., Carr, V., Evans, M., … McGrath, J. (2004). Demographic and clinical correlates of comorbid substance use disorders in psychosis: Multivariate analyses from an epidemiological sample. Schizophrenia Research, 66(2), 115–124. doi:10.1016/S0920-9964(03)00130-0
  • Lauritzen, G.Ravndal, &, E. (2004). Introduction of the EuropASI in Norway, clinical and research experiences from cost-effectiveness study. Journal of Substance Use, 9, 141–146.
  • Lehman, A.F., Myers, C.P., Thompson, J.W., & Corty, E. (1993). Implications of mental and substance use disorders: A comparison of single and dual diagnosis patients. The Journal of Nervous and Mental Disease, 181(6), 337–399. doi:10.1097/00005053-199306000-00005
  • Leonhard, C., Mulvey, K., Gastfriend, D.R., & Shwartz, M. (2000). The Addiction Severity Index: A field study of internal consistency and validity. Journal of Substance Abuse Treatment, 18(2), 129–135. doi:10.1016/S0740-5472(99)00025-2
  • Magura, S., Staines, G., Kosanke, N., Rosenblum, A., Foote, J., Deluca, A., & Bali, P. (2003). Predictive validity of the ASAM patient placement criteria for naturalistically matched vs. mismatched alcoholism patients. The American Journal on Addictions, 12(5), 386–397. doi:10.1111/j.1521-0391.2003.tb00482.x
  • McGahan, P.L., Griffith, J.A., Parente, R., & McLelland, T.A. (1986). ASI composite score manual. Philadelphia, PA: Treatment Research Institute. http://www.tresearch.org/wp-content/uploads/2012/09/CompositeManual.pdf
  • McGovern, M.P., Xie, H., Acquilano, S., Segal, S.R., & Drake, R.E. (2007). Addiction Treatment Services and Co-Occurring Disorders. The ASAM-PPC-2R Taxonomy of Program Dual Diagnosis Capability. Journal of Addiction Disorders, 26(3), 27–37. doi:10.1300/J069v26n03_04
  • McLellan, T.A., Kushner, H., Metzger, D., Peters, R., Smith, I., Grissom, G., … Argeriou, M. (1992). The fifth edition of the Addiction Severity Index. Journal of Substance Abuse Treatment, 9(3), 199–213. doi:10.1016/0740-5472(92)90062-S
  • Mee-Lee, D., Shulman, G.D., Fishman, M., Gastfriend, D.R., & Griffith, J.H. (2001). ASAM PPC-2R. ASAM Patient Placement Criteria for the treatment of Substance-Related Disorders. Chevy Chase, MD: American Society of Addiction Medicine, Inc.
  • Melberg, H.O., Lauritzen, G., & Ravndal, E. (2003). Benefits for who and to what cause? Hvilken nytte, for hvem og til hvilken kostnad? En prospektiv studie av stoffmisbrukere i behandling. SIRUS-rapport nr. 4/2003, Oslo: Statens institutt for rusmiddelforskning.
  • Minkoff, K. (2008). Dual diagnosis enhanced programs. Journal of Dual Diagnosis, 4(3), 320–325. doi:10.1080/15504260802076314
  • Minkoff, K., Zweben, J.Rosenthal,, R., & RiesR. K., (2003). Developing service intensity criteria and program categories for individuals with co-occurring disorders. Journal of Addictive Diseases, 12, 113–129.
  • Lauritzen, G., & Ravndal, E. (2004). Introduction of the EuropASI in Norway: Clinical and research experiences from cost-effectiveness study. Journal of Substance Use, 9(3–4), 141–146. doi:10.1080/14659890410001697415
  • Ravndal, E., Vaglum, P., & Lauritzen, G. (2005).Completion of long-term inpatient treatment of drug abusers: A prospective study from 13 different units. European Addiction Research, 11, 180–185.
  • Rokkan, T., & Brandtsberg-Dahl, A. (2003). Tyrili 10 years after–An evaluation of Frankmotunet. Tyrili 10 år etter–en evaluering av Frankmotunet (Tyrili skiftserie nr. 5). Oslo: Tyrili Forskning og Utvikling.
  • Schulte, S., Meier, P.S., Stirling, J., & Berry, M. (2008). Treatment approa-ches for dual diagnosis clients in England. Drug and Alcohol Review, 27(6), 650–658. doi:10.1080/09595230802392816
  • Schulte, S.J., Meier, P.S., Stirling, J., & Berry, M.(2010). Unrecognised dual diagnosis–A risk factor for dropout of addiction treatment. Mental Health and Substance Use, 3(2), 94–109. doi:10.1080/17523281003705199
  • Sharon, E., Krebs, C., Turner, W., Desai, N., Binus, G., Penk, W., & Gastfriend, D.R. (2003). Predictive validity of the ASAM placement criteria for hospital utilization. Journal of Addictive Diseases, 22(Suppl. 1), 79–93.
  • Staines, G., Kosanke, N., Magura, S., Bali, P., Foote, J., & Deluca, A. (2003). Convergent validity of the ASAM patient placement criteria, using a standardized computer algorithm. Journal of Addictive Diseases, 22(Suppl. 1), 61–77.
  • Stallvik, M., & Gastfriend, D.R. (2014). Predictive and convergent validity of the ASAM Criteria in Norway. Addiction Research and Theory. doi:10.3109/16066359.2014.910512
  • World Health Organization. (1993). The ICD-10 classification of mental and behavioral disorders. Diagnostic criteria for research. Geneva: Author.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.